Thor Medical ASA

OL:TRMED Norway Biotechnology
Market Cap
$147.05 Million
Nkr1.68 Billion NOK
Market Cap Rank
#21366 Global
#101 in Norway
Share Price
Nkr4.73
Change (1 day)
+3.73%
52-Week Range
Nkr2.20 - Nkr5.40
All Time High
Nkr121.16
About

Thor Medical ASA produces and supplies alpha-particle emitters for cancer therapy in Norway. It develops Ra224, an isotope of radium; Pb-212, a radioactive isotope of lead; and Th-228, a radioactive isotope of thorium. The company was incorporated in 2009 and is headquartered in Oslo, Norway.

Thor Medical ASA (TRMED) - Cash Flow Conversion Efficiency

Latest cash flow conversion efficiency as of December 2024: 0.000x

Based on the latest financial reports, Thor Medical ASA (TRMED) has a cash flow conversion efficiency ratio of 0.000x as of December 2024.

Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (Nkr-5.74K) by net assets (Nkr337.10 Million). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.

Thor Medical ASA - Cash Flow Conversion Efficiency Trend (2020–2024)

This chart illustrates how Thor Medical ASA's cash flow conversion efficiency has evolved over time, based on yearly financial data. Explore and compare other companies by cash flow conversion efficiency.

Thor Medical ASA Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Thor Medical ASA ranked by their cash flow conversion efficiency.

Annual Cash Flow Conversion Efficiency for Thor Medical ASA (2020–2024)

The table below shows the annual cash flow conversion efficiency of Thor Medical ASA from 2020 to 2024.

Year Net Assets Operating Cash Flow Cash Flow Conversion Efficiency Change
2024-12-31 Nkr337.10 Million Nkr-23.70 Million -0.070x +70.17%
2023-12-31 Nkr271.93 Million Nkr-64.09 Million -0.236x +96.32%
2022-12-31 Nkr63.84 Million Nkr-409.08 Million -6.408x -123.17%
2021-12-31 Nkr140.52 Million Nkr-403.46 Million -2.871x -28.83%
2020-12-31 Nkr178.67 Million Nkr-398.21 Million -2.229x --